Healthcare Costs with Tiotropium Plus Usual Care versus Usual Care Alone Following 1 Year of Treatment in Patients with Chronic Obstructive Pulmonary Disorder (COPD)

Author： Mitchell Friedman  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.11, 2004-01, pp. : 741-749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year

By Torrance G.  

PharmacoEconomics, Vol. 16, Iss. 5, 1999-11 ,pp. : 499-520

Adis International

Access to resources Recommend Favorite

COPD self-management cost saving versus usual care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 523, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Formoterol plus tiotropium bromide is more effective than either drug alone in patients with acute exacerbation of chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives

By Mittmann Nicole  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand

By Saokaew Surasak  

International Journal of Clinical Pharmacy, Vol. 34, Iss. 1, 2012-02 ,pp. : 105-112

Springer Publishing Company

Access to resources Recommend Favorite